salicylic acid has been researched along with rivaroxaban in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Alfaro-Ponce, DL; Altamirano-Castillo, A; Araiza-Garaygordobil, D; Arias-Mendoza, A; Belderrain-Morales, N; Briseño-De la Cruz, JL; Cabello-López, A; Gonzalez-Pacheco, H; Gopar-Nieto, R; Martinez-Amezcua, P; Martínez-Ríos, MA; Mendoza-García, S; Ontiveros-Mercado, H; Piña-Reyna, Y; Ruiz-Beltrán, M; Sarabia-Chao, V; Sierra-Lara Martínez, D | 1 |
1 trial(s) available for salicylic acid and rivaroxaban
| Article | Year |
|---|---|
Dual Antiplatelet Therapy Versus Antiplatelet Monotherapy Plus Oral Anticoagulation in Patients with Acute Coronary Syndrome and Coronary Artery Ectasia: Design and Rationale of OVER-TIME Randomized Clinical Trial.
Topics: Acute Coronary Syndrome; Anticoagulants; Coronary Vessels; Dilatation, Pathologic; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Rivaroxaban; Salicylic Acid; Treatment Outcome | 2022 |
1 other study(ies) available for salicylic acid and rivaroxaban
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |